Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Makito Miyake, Jumpei Tokumaru, Hiroshi Oi, Hiroshi Kitagawa, Kiyohide Fujimoto, Naotaka Nishiyama, Hiroshi Kitamura |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
por: Kylie Yen‐Yi Lim, et al.
Publicado: (2025)
por: Kylie Yen‐Yi Lim, et al.
Publicado: (2025)
Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
por: Shugo Yajima, et al.
Publicado: (2025)
por: Shugo Yajima, et al.
Publicado: (2025)
Time to abandon routine urine analysis prior to Bacillus Calmette–Guérin administration in asymptomatic patients
por: Antti Nummi, et al.
Publicado: (2025)
por: Antti Nummi, et al.
Publicado: (2025)
Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
por: Yuki Teramoto, et al.
Publicado: (2026)
por: Yuki Teramoto, et al.
Publicado: (2026)
Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
por: Alison Hiong, et al.
Publicado: (2025)
por: Alison Hiong, et al.
Publicado: (2025)
Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
por: Serdar Turan, et al.
Publicado: (2025)
por: Serdar Turan, et al.
Publicado: (2025)
Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
por: Katherina Y. Chen, et al.
Publicado: (2026)
por: Katherina Y. Chen, et al.
Publicado: (2026)
Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
por: Amandeep Arora, et al.
Publicado: (2025)
por: Amandeep Arora, et al.
Publicado: (2025)
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
por: Liam Mannion, et al.
Publicado: (2024)
por: Liam Mannion, et al.
Publicado: (2024)
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
por: Kira Furlano, et al.
Publicado: (2024)
por: Kira Furlano, et al.
Publicado: (2024)
Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
por: Sean Lim, et al.
Publicado: (2026)
por: Sean Lim, et al.
Publicado: (2026)
Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
por: Jacob Hanna, et al.
Publicado: (2026)
por: Jacob Hanna, et al.
Publicado: (2026)
Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
por: Rachel Weng, et al.
Publicado: (2025)
por: Rachel Weng, et al.
Publicado: (2025)
Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
por: Chase Peng Yun Ng, et al.
Publicado: (2025)
por: Chase Peng Yun Ng, et al.
Publicado: (2025)
A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
por: John Lahoud, et al.
Publicado: (2024)
por: John Lahoud, et al.
Publicado: (2024)
Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
por: Cameron E. Alexander, et al.
Publicado: (2024)
por: Cameron E. Alexander, et al.
Publicado: (2024)
Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
por: Yu Ishizuya, et al.
Publicado: (2026)
por: Yu Ishizuya, et al.
Publicado: (2026)
Patient experience of bladder cancer: A data linkage study
por: Snehadhar Shah, et al.
Publicado: (2024)
por: Snehadhar Shah, et al.
Publicado: (2024)
Health utility value of overactive bladder in Japanese older adults
por: Takashi Yoshioka, et al.
Publicado: (2024)
por: Takashi Yoshioka, et al.
Publicado: (2024)
Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
por: Joshua D. Cabral, et al.
Publicado: (2026)
por: Joshua D. Cabral, et al.
Publicado: (2026)
Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
por: Liwu Guo, et al.
Publicado: (2024)
por: Liwu Guo, et al.
Publicado: (2024)
Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
por: Hugo Klempfner, et al.
Publicado: (2024)
por: Hugo Klempfner, et al.
Publicado: (2024)
Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
por: Yin Zhou, et al.
Publicado: (2024)
por: Yin Zhou, et al.
Publicado: (2024)
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery
por: Sezgin Yeni, et al.
Publicado: (2025)
por: Sezgin Yeni, et al.
Publicado: (2025)
Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
por: Rodolfo Hurle, et al.
Publicado: (2025)
por: Rodolfo Hurle, et al.
Publicado: (2025)
The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
por: Kunal K. Sindhu, et al.
Publicado: (2024)
por: Kunal K. Sindhu, et al.
Publicado: (2024)
Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
por: Mohammed Al‐Zubaidi, et al.
Publicado: (2024)
por: Mohammed Al‐Zubaidi, et al.
Publicado: (2024)
Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
por: Rebecca Martin, et al.
Publicado: (2025)
por: Rebecca Martin, et al.
Publicado: (2025)
Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder
por: William Chui, et al.
Publicado: (2024)
por: William Chui, et al.
Publicado: (2024)
Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
por: Thomas Philip Cahill, et al.
Publicado: (2024)
por: Thomas Philip Cahill, et al.
Publicado: (2024)
Bibliometric analysis of focal therapy in prostate cancer research
por: Mohammed Shahait, et al.
Publicado: (2024)
por: Mohammed Shahait, et al.
Publicado: (2024)
Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer
por: Alexander Hintze Hillers, et al.
Publicado: (2024)
por: Alexander Hintze Hillers, et al.
Publicado: (2024)
Single‐port robot‐assisted ureterolysis for retroperitoneal fibrosis: A less invasive path to functional recovery
por: Filippo Carletti, et al.
Publicado: (2026)
por: Filippo Carletti, et al.
Publicado: (2026)
Step‐by‐step: A traction‐based fenestration method for vasoepididymostomy
por: Kosuke Kojo, et al.
Publicado: (2025)
por: Kosuke Kojo, et al.
Publicado: (2025)
Incidental crossed fused renal ectopia detected during prostate cancer staging: A photorealistic three‐dimensional rendering
por: Kei Ushijima, et al.
Publicado: (2025)
por: Kei Ushijima, et al.
Publicado: (2025)
Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
por: Nadia Rokan, et al.
Publicado: (2025)
por: Nadia Rokan, et al.
Publicado: (2025)
Preoperative pelvic floor muscle diameter as a predictor of postoperative urinary incontinence in robotic‐assisted laparoscopic total prostatectomy
por: Sho Hashimoto, et al.
Publicado: (2025)
por: Sho Hashimoto, et al.
Publicado: (2025)
Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
por: Sofia Mesquita, et al.
Publicado: (2025)
por: Sofia Mesquita, et al.
Publicado: (2025)
Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
por: Samantha Shekar, et al.
Publicado: (2025)
por: Samantha Shekar, et al.
Publicado: (2025)
Ejemplares similares
-
Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
por: Kylie Yen‐Yi Lim, et al.
Publicado: (2025) -
Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
por: Shugo Yajima, et al.
Publicado: (2025) -
Time to abandon routine urine analysis prior to Bacillus Calmette–Guérin administration in asymptomatic patients
por: Antti Nummi, et al.
Publicado: (2025) -
Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
por: Yuki Teramoto, et al.
Publicado: (2026) -
Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
por: Alison Hiong, et al.
Publicado: (2025)